BioCatalyst

Tirzepatide — catalyst calendar

3 verified catalyst event(s) referencing Tirzepatide, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity an
Phase 2 · Overweight, Obesity
 LLY ELI LILLY & Co Tirzepatide ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-11 (month)
in 4mo
ESTIMATED
 READOUT
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 D
Phase 3 · Type 1 Diabetes, Obesity
 LLY ELI LILLY & Co Tirzepatide ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-11 (month)
in 4mo
ESTIMATED
 READOUT
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and
Phase 3 · Type 1 Diabetes, Obesity
 LLY ELI LILLY & Co Tirzepatide ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.